Personal lubricant

CYNTHIA BAILEY PARTNERS WITH KINDRA TO RAISE AWARENESS ABOUT VAGINAL HEALTH DURING MENOPAUSE

Retrieved on: 
Thursday, March 28, 2024

NEW YORK, March 28, 2024 /PRNewswire/ -- Kindra , the menopause and vaginal health brand, announces actress and model Cynthia Bailey as brand ambassador to raise awareness for menopause and vaginal wellness by heightening the conversation around the sexual health of women at every age.

Key Points: 
  • NEW YORK, March 28, 2024 /PRNewswire/ -- Kindra , the menopause and vaginal health brand, announces actress and model Cynthia Bailey as brand ambassador to raise awareness for menopause and vaginal wellness by heightening the conversation around the sexual health of women at every age.
  • As long-term champions for breaking down stigmas around women's health, Bailey and Kindra share a vision to increase conversations around the vast spectrum of needs as it relates to a woman's sexual health.
  • Vaginas have no expiration date, and Kindra's array of care, solutions, and services cater to the needs of vaginal health and sexual wellness.
  • Whether it's embracing the transitions of menopause, tackling contraceptive dryness, or navigating postpartum challenges, Kindra provides women and their healthcare practitioners with clinically-backed, trusted solutions and educational resources on vaginal health and sexual wellness.

MysteryVibe partners with Havas Lynx and makes history by showcasing the very first sex toy on billboards in the U.S.

Retrieved on: 
Monday, March 25, 2024

The billboard is the first of its kind, making history in sexual wellness advertising by showcasing a visible sex toy in Central Manhattan.

Key Points: 
  • The billboard is the first of its kind, making history in sexual wellness advertising by showcasing a visible sex toy in Central Manhattan.
  • "We are incredibly lucky to have been a part of many 'firsts' in women's health over the past decade," shared Soumyadip Rakshit, CEO and cofounder, MysteryVibe.
  • "Not only are we honored to support a campaign that enables women to overcome taboos around menopause, we know that discomfort shouldn't be normalized."
  • In conjunction with the billboard, the campaign contains other educational elements backed by award-winning reproductive scientist Professor Joyce Harper .

KINDRA LAUNCHES FIRST-EVER COMPREHENSIVE VAGINAL HEALTH SYSTEM: THE DAILY V SYSTEM

Retrieved on: 
Monday, March 25, 2024

NEW YORK, March 25, 2024 /PRNewswire/ -- Today, Kindra, the sex-positive vaginal health brand, announced the launch of the first-ever comprehensive vaginal health product system - the Daily V System. The 4-part daily regimen of Kindra products includes: Daily Vaginal Lotion, V Relief Serum, Soothe Bath Soak and the Core Supplement meant to support vulvar and vaginal skin for optimal vaginal health and sexual wellness.

Key Points: 
  • NEW YORK, March 25, 2024 /PRNewswire/ -- Today, Kindra , the sex-positive vaginal health brand, announced the launch of the first-ever comprehensive vaginal health product system - the Daily V System .
  • The 4-part daily regimen of Kindra products includes: Daily Vaginal Lotion , V Relief Serum , Soothe Bath Soak and the Core Supplement meant to support vulvar and vaginal skin for optimal vaginal health and sexual wellness.
  • This hormone-free system is designed to provide targeted relief and support for daily vulvar and vaginal health needs.
  • As part of its launch of the Daily V System, Kindra has partnered with pelvic floor physical therapist Dr. Sara Reardon, known online as The Vagina Whisperer, on a video about the importance of a daily vaginal health regimen for long-term vulvovaginal health and comfort.

Daré Bioscience Announces FDA Clearance of Investigational New Drug (IND) Application for DARE-VVA1, a Novel Intravaginal Formulation of Tamoxifen for Moderate to Severe Dyspareunia, a Symptom of Vulvar and Vaginal Atrophy Associated with Menopause

Retrieved on: 
Thursday, December 7, 2023

With the IND clearance from the FDA, Daré can begin planning for an anticipated Phase 2 randomized, double-blinded, placebo-controlled, dose-finding clinical study of DARE-VVA1.

Key Points: 
  • With the IND clearance from the FDA, Daré can begin planning for an anticipated Phase 2 randomized, double-blinded, placebo-controlled, dose-finding clinical study of DARE-VVA1.
  • VVA is an inflammation and thinning of the vaginal epithelium due to chronic hypo-estrogenism, which is the reduction in levels of circulating estrogen.
  • Typical symptoms include vaginal dryness, itching, burning, and painful intercourse (dyspareunia), adversely impacting quality of life.
  • Products containing estrogen are commonly used to treat VVA but some women cannot or choose not to use these products, including those with a history of hormone-receptor positive (HR+) breast cancer.

Pharmavite Announces $425 Million Acquisition of Bonafide Health to Become Leader in Women’s Health

Retrieved on: 
Thursday, November 30, 2023

Pharmavite LLC, the leading nutrition powered wellness company and makers of Nature Made® vitamins, today announces its acquisition of Bonafide Health, the women’s health company creating a new standard in managing the journey of menopause.

Key Points: 
  • Pharmavite LLC, the leading nutrition powered wellness company and makers of Nature Made® vitamins, today announces its acquisition of Bonafide Health, the women’s health company creating a new standard in managing the journey of menopause.
  • Through the acquisition of Bonafide Health, Pharmavite is expanding and complementing its existing women’s health business comprised of Uqora, a cutting-edge urinary tract health brand, and Equelle, the only supplement with S-equol that is clinically shown to naturally address the root cause of symptoms related to estrogen decline.
  • “We’re thrilled to welcome Bonafide Health to Pharmavite.
  • Pharmavite is that partner,” said Michael Satow Co-Founder and CEO of Bonafide Health.

pH-D® Feminine Health, the Industry Leader in Holistic Feminine Hygiene and Wellness Solutions, Launches First Annual pH-D® Pulse Poll

Retrieved on: 
Monday, October 30, 2023

NASHVILLE, Tenn., Oct. 30, 2023 /PRNewswire/ -- pH-D Feminine Health announced today an industry first—the release of their first annual pH-D® Pulse Poll, a look at women's most compelling feminine care issues today. According to the survey, sponsored by pH-D Feminine Health and conducted by TSG Consumer, a stunning 74% of women report feeling insecure or embarrassed by vaginal odor. Another 28% of all women surveyed report feeling insecure about vaginal dryness. 

Key Points: 
  • NASHVILLE, Tenn., Oct. 30, 2023 /PRNewswire/ -- pH-D Feminine Health announced today an industry first—the release of their first annual pH-D® Pulse Poll, a look at women's most compelling feminine care issues today.
  • According to the survey, sponsored by pH-D Feminine Health and conducted by TSG Consumer, a stunning 74% of women report feeling insecure or embarrassed by vaginal odor.
  • The pH-D® Pulse Poll also found:
    Many women note a love/hate relationship with their vagina (being both a source of pain and pleasure) and oftentimes a nuisance.
  • So popular, pH-D Feminine Health sells one boric acid vaginal suppository every 20 seconds.

Dr. Wolff's Vagisan Introduces Hormone-Free Moisturising Cream and Moisturising Cremolum, Clinically Proven to Soothe Vaginal Dryness

Retrieved on: 
Thursday, October 19, 2023

Hong Kong SAR, China--(Newsfile Corp. - October 19, 2023) - Dr. Wolff's Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum for women troubled by vaginal dryness while experiencing menopause.

Key Points: 
  • Hong Kong SAR, China--(Newsfile Corp. - October 19, 2023) - Dr. Wolff's Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum for women troubled by vaginal dryness while experiencing menopause.
  • Vaginal secretions gradually decrease as a woman ages, resulting in decreased lubrication and elasticity of the vaginal tissue.
  • This can result in vaginal dryness and associated symptoms such as dryness, itching, burning, and pain3.
  • Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.

Dr. Wolff Group: Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness

Retrieved on: 
Thursday, October 26, 2023

Dr. Wolff Group: Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness

Key Points: 
  • Dr. Wolff Group: Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness
    The issuer is solely responsible for the content of this announcement.
  • Dr. Wolff’s Vagisan introduces hormone-free Moisturising Cream and Moisturising Cremolum, clinically proven to soothe vaginal dryness
    HONG KONG SAR - Media OutReach - 18 October 2023 - Many woman experiencing menopause are troubled by vaginal dryness.
  • This can result in vaginal dryness and associated symptoms such as dryness, itching, burning, and pain3.
  • Vaginal hormone-free moisturising cream is not inferior to an estriol cream for treating symptoms of vulvovaginal atrophy: Prospective, randomised study.

Phenology's Menopause Study Unveils Key Insights for Transformative Innovation

Retrieved on: 
Wednesday, October 25, 2023

The study findings paint a vivid picture of the diverse experiences women have of this complex transition and reveal new insights that can transform care.

Key Points: 
  • The study findings paint a vivid picture of the diverse experiences women have of this complex transition and reveal new insights that can transform care.
  • View the full release here: https://www.businesswire.com/news/home/20231025455346/en/
    A random sample of 200 women in the study illustrates the variation of menopause symptom signatures.
  • (Graphic: Business Wire)
    Most astonishing was the discovery of more than 15,000 unique menopause symptom signatures in the data set.
  • Releasing this study underscores the brand's dedication to enhancing the scientific understanding of menopause, paving the way for meaningful innovation.

World Menopause Day: International SOS Encourages Organisations to Provide Workplace Support and Raise Awareness on Menopause

Retrieved on: 
Wednesday, October 18, 2023

International SOS, the world's leading health and security risk services company, joins the world in supporting World Menopause Day on 18 October.

Key Points: 
  • International SOS, the world's leading health and security risk services company, joins the world in supporting World Menopause Day on 18 October.
  • The International Day is to raise awareness of menopause and is dedicated to acknowledging and supporting women’s health during menopause.
  • International SOS encourages organisations to create a supportive, inclusive workplace and offers valuable insights to help organisations and employees navigate the menopause transition.
  • According to the World Health Organization , menopause typically occurs between the ages of 45 and 55, and the average age of menopause is 51.